Abiomed Inc - Company Profile
Powered by
All the data and insights you need on Abiomed Inc in one report.
- Save hours of research time and resources with
our up-to-date Abiomed Inc Strategy Report
- Understand Abiomed Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
Abiomed Inc (Abiomed) is a medical device company that develops, manufactures, and markets circulatory support devices. The devices replace or assist the pumping function in a failing heart. The company’s heart support and recovery product portfolio includes Impella heart pumps (catheter-based devices including micro heart pumps, expandable catheter pumps and axial flow pumps) and Breethe system (implantable cardiac and respiratory assist devices). Abiomed also offers online clinical support through Impella Connect, on-call assistance and on-site assistance for health workers in hospitals. The company sells its products through direct sales and distributors in South America, Europe, Asia, and the Middle East. Abiomed is headquartered in Danvers, Massachusetts, the US.
Abiomed Inc premium industry data and analytics
Products and Services
Products | Services | Brands |
---|---|---|
- | - | - |
Impella 2.5 Catheter | Impella Connect- Cloud-based remote monitoring | Abiomed |
Impella CP heart pump | Impella | |
XYZ | XYZ | |
XYZ | XYZ | |
XYZ | XYZ |
Competitor Comparison
Key Parameters | Abiomed Inc | Abbott Laboratories | Medtronic Plc | Boston Scientific Corp | Terumo Corp |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | Ireland | United States of America | Japan |
City | Danvers | Abbott Park | Dublin | Marlborough | Shibuya-Ku |
State/Province | Massachusetts | Illinois | - | Massachusetts | Tokyo |
No. of Employees | 2,003 | 114,000 | 95,000 | 48,000 | 30,207 |
Entity Type | Private | Public | Public | Public | Public |
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Todd A. Tetreault | Chief Financial Officer | Senior Management | - | - |
Will Danzinger | Chief Operating Officer | Senior Management | - | - |
Thorsten Siess, Ph.D. | Managing Director; Vice President; Chief Technology Officer | Senior Management | - | - |
Charles A. Simonton, MD | Executive Vice President; Chief Medical Officer | Senior Management | 2020 | - |
Andrew J. Greenfield | President | Senior Management | - | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer